Search Results

comprising international leaders in GPCRs pharmacology, immunology, drug discovery and development for auto-immune

GPR84 is a G protein-coupled receptor primarily expressed in myeloid cells that constitute the innate immune These results define a unique role of GPR84 in innate immune cells and intestinal inflammation, and suggest

Tissue expression levels of β-Arrestins and their implications in cancer In addition to molecular interactions expression data in healthy tissues from the Genotype-Tissue Expression (GTEx) database with data from cancer samples in The Cancer Genome Atlas (TCGA) through the Gene Expression Profiling Interactive Analysis (GEPIA) tool, it is evident that β-arrestin expression is dysregulated in many cancer types. In certain cancer types, only one β-arrestin isoform's expression may be altered, while the other remains

Gi/o GPCRs drive the formation of actin-rich tunneling nanotubes in cancer cells via a Gβγ/PKCα/FARP1 Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 Autocrine proteinase-activated receptor signaling in PC3 prostate cancer cells. Multi-omics integration analysis of GPCRs in pan-cancer to uncover inter-omics relationships and potential

in autism spectrum disorders GPCRs in Oncology and Immunology Molecular characterization of breast cancer 2023 Half Year And Second Quarter Financial Results And Provides Corporate Update Sosei Heptares and Cancer Research UK Announce the Dosing of the First Patient in a Phase I/IIa Trial with Cancer Immunotherapy

Metabolite Concentrations in Portal Venous Blood as a Possible Mechanism for Microbiota Effects on the Immune System, and Western Diseases Lactate receptor GPR81 drives breast cancer growth and invasiveness through

Bursaphelenchus xylophilus and B. mucronatus GPCRs in Oncology and Immunology GPCR signaling contributes to immune TRUQAP™ (capivasertib) plus fulvestrant approved in the US for patients with advanced HR-positive breast cancer

mesenchymal stem cells in multiple sclerosis patients Multiple sclerosis (MS) is a specific type of chronic immune-mediated disease in which the immune responses are almost run against the central nervous system (CNS). Chemokine/chemokine receptor axes play a pivotal role in the recruitment and oriented trafficking of immune

immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary innate immune Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers

In various pathological conditions, including cancer, aberrant ERK activity can lead to uncontrolled ERK: a double-edged sword in cancer. ERK-dependent apoptosis as a potential therapeutic strategy for cancer. Cells, 10(10), 2509.

phosphoinositide 3-kinase (PI3K) pathway, which plays fundamental roles in growth, metabolism, and immunity PI3Kγ is a critical component in multiple immune signaling processes and is dependent on activation by

macrophage migration during tissue inflammation From odor to oncology: non-canonical odorant receptors in cancer TIMS-TOF MS) A rapid, tag-free way to purify functional GPCRs tANCHOR fast and cost-effective cell-based immunization

Postdoctoral research position Adhesion GPCRs The G Protein-Coupled Receptor GPR56 Is an Inhibitory Checkpoint receptors regulate a wide spectrum of endocrine tumors G protein coupled receptor transcripts in human immune

focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer

provided a substantial body of evidence demonstrating that platelets also participate in host innate immunity interactions with neutrophils enhance neutrophil activation and are often crucial to induce a sufficient immune

in glioblastoma activated by acidic extracellular microenvironment Drosophila cytokine GBP2 exerts immune founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer

Functional Assessment of Cancer-Linked Mutations in Sensitive Regions of Regulators of G Protein Signaling Deletion of macrophage Gpr101 disrupts their phenotype and function dysregulating host immune responses

that regulate receptor phosphorylation and signaling termination, GRK2, which is highly expressed by immune

novel proteins for biology and health research Innovate UK announced the winners of its Transforming Cancer Therapeutics grant, which focuses on developing life-changing cancer treatments. power of many: Multilevel targeting of representative chemokine and metabolite GPCRs in personalized cancer

phosphorylation events highlights a nuanced regulatory mechanism that could be crucial in contexts such as cancer GPCR-dependent pathways by growth factor signaling might contribute to altered cellular behaviors in cancer

Dysfunction of B2R is also closely related to cancers and hereditary angioedema (HAE).

GPCRs in Oncology and Immunology Ovarian cancer G protein-coupled receptor 1 (OGR1) deficiency exacerbates Colorectal cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004-2018.

September 2022 "T cells are master regulators of the immune response tuning, among others, B cells, macrophages

discovered the vast potential for GPCR-targeting drugs in treating a range of health conditions, from cancer

are ancient large DNA viruses that have exploited gene capture as part of their strategy to escape immune

Expression of GPR84 is strongly up regulated in immune cells in a range of pro-inflammatory settings

receptor (GPCR), known as Mas-related G protein-coupled receptor-B2 (MRGPRB2), plays important roles in immune

is activated by the three chemokine ligands CXCL9, CXCL10, and CXCL11 and enables the recruitment of immune